Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $10
Analysts Are Bullish on These Healthcare Stocks: Bioventus (BVS), Sight Sciences (SGHT)
Morgan Stanley Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $7
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $10
Sight Sciences Analyst Ratings
Sight Sciences Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Favorable Reimbursement Outlook
Lake Street Initiates Coverage on Sight Sciences With Buy Rating, $10 Price Target
Morgan Stanley Sticks to Their Hold Rating for Sight Sciences (SGHT)
Sight Sciences (SGHT) Gets a Hold From Piper Sandler
Sight Sciences Analyst Ratings
Needham Maintains Sight Sciences(SGHT.US) With Hold Rating
Sight Sciences Analyst Ratings
Morgan Stanley Raises Price Target on Sight Sciences to $6.50 From $5.40, Keeps Equalweight Rating
Sight Sciences Analyst Ratings
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6.5
Piper Sandler Reiterates Neutral on Sight Sciences, Raises Price Target to $6